Stanford University School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. Risk of cancer development associated with disease-modifying therapies for multiple sclerosis: study protocol for a systematic review and meta-analysis of randomised and non-randomised studies

    Systematic reviews, Vol. 13, Núm. 1, pp. 263